与骨质疏松症患者的teriparatide相比,与romosozumab相关的骨关节炎风险:一个向试验仿真研究
Masaki Hatano1, Yusuke Sasabuchi2, Akira Okada3
1Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Annals of the rheumatic diseases
|July 12, 2025
概括
在骨质疏松症患者中,罗莫苏祖马布显示骨关节炎的风险较低,而不是teriparatide. 这包括膝关节骨关节炎发病率的显著减少.
科学领域:
- 风湿病学和内分泌学.
- 药理学研究 药理学研究
- 临床试验仿真临床试验仿真
背景情况:
- 骨质疏松症的治疗需要仔细考虑潜在的副作用.
- 对比疗效研究对于指导治疗决策至关重要.
研究的目的:
- 为了比较患有骨质疏松症的个体中骨关节炎的发病率,启动罗莫苏祖马布与活性比较剂.
- 为了评估关节特异性骨关节炎 (膝盖,部,手) 一年后的结果.
主要方法:
- 一项模拟目标试验的新用户比较有效性研究.
- 使用了2019-2022年的行政索赔数据,用于年龄≥50岁的个人.
- 应用治疗权重的逆概率 (IPTW) 和审查权重的逆概率 (IPCW) 进行可靠的分析.
主要成果:
- 与teriparatide相比,Romosozumab与较低的骨关节炎风险相关 (ARR,1.1%;RR,0.79).
- 在膝关节骨关节炎中观察到显著的减少 (ARR,0.8%;RR,0.79).
- 趋势表明部和手部骨关节炎的风险较低,尽管在统计学上并不显著.
结论:
- 在骨质疏松症患者中,罗莫苏zumab 显示与 teriparatide 相比,骨关节炎的风险降低.
- 在膝关节骨关节炎发病率中观察到最明显的效应.
- 对于部和手部骨关节炎的结果,可能需要进一步调查.
相关概念视频
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Relative Risk
351
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
351
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K


